gadopiclenol: Clinical Trials

4 trials of gadopiclenol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow gadopiclenol: new trials by email Literature Review of gadopiclenol trials Research Report on gadopiclenol

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers
gadopiclenol, Placebo - Pharmacokinetics
Phase 1CompletedGuerbet272021-05-102021-10-07
Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function
P03277 - Renal Insufficiency, Healthy Volunteers
Phase 1CompletedGuerbet402017-10-132019-10-22
Cardiac Safety Evaluation of P03277
P03277 0.1 mmol/kg, Moxifloxacin 400mg, NaCl 0.9% - Healthy Volunteers
Phase 1CompletedGuerbet482017-08-212022-07-18
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
P03277, Placebo - Healthy Volunteers, Brain Lesion
Phase 1 / Phase 2CompletedGuerbet1422013-11-252021-05-14

Conditions studied

Renal Insufficiency (1)

Sponsors

Guerbet (4)

Countries

Belgium (2)  ·  Japan (1)  ·  Moldova (1)  ·  Romania (1)

Top investigators

Frederic Vanhoutte, MD (1)  ·  Jing Hao (1)  ·  Penescu Mircea, MD (1)  ·  Wouter Haazen, MD (1)

Results publications

PMID 30870257, PMID 34197356

NIH funding

2017 (1)